Generation of an induced pluripotent stem cell line from a Chinese Han child with catecholaminergic polymorphic

Wei Liu1, Ting Liu2, Tingting Xiao3

  • 1Department of Cardiology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, No. 355 Luding Road, Shanghai 200062, China.

Stem Cell Research
|June 9, 2022
PubMed

Insights

Researchers generated induced pluripotent stem cells (iPSCs) from a patient with catecholaminergic polymorphic ventricular tachycardia (CPVT). These iPSCs carry the TECRL mutation, offering a new tool to study CPVT mechanisms.

Area of Science:

  • Cardiology
  • Stem Cell Biology
  • Genetics

Background:

  • Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic heart rhythm disorder.
  • The TECRL gene, encoding an endoplasmic reticulum protein, is implicated in CPVT.
  • Understanding TECRL's role in cardiomyocyte calcium handling is crucial for CPVT pathogenesis.

Purpose of the Study:

  • To generate a patient-specific induced pluripotent stem cell (iPSC) line from a CPVT patient with a known TECRL mutation.
  • To establish a cellular model for investigating the mechanisms underlying TECRL-associated CPVT.
  • To provide a valuable research platform for drug discovery and therapeutic strategies.

Main Methods:

  • Generated patient-derived iPSCs using Sendiavirus-mediated reprogramming from peripheral blood mononuclear cells.
  • Characterized iPSC pluripotency, differentiation capacity, and karyotype stability.
  • Confirmed the presence of the pathogenic TECRL mutation in the generated iPSC line.

Main Results:

  • Successfully generated a stable iPSC line from a CPVT patient.
  • The iPSC line demonstrated pluripotency markers and spontaneous differentiation into three germ layers.
  • The iPSC line maintained a normal karyotype and harbored the specific TECRL mutation.

Conclusions:

  • Patient-derived iPSCs carrying the TECRL mutation provide a robust model for CPVT research.
  • This iPSC resource facilitates the study of TECRL's function in cardiac calcium homeostasis.
  • The developed cell line is instrumental for elucidating CPVT mechanisms and exploring potential therapies.

Related Concept Videos